Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3642
Selected: 0
NCT IDTitle
NCT07035925Study Evaluating the Safety and Efficacy of an ECM Hydrogel for the Treatment of Anorectal Fistulas
NCT05245006PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer
NCT04772885A Single and Multiple Ascending Dose Trial of KT-474 in Healthy Adult Volunteers and Patients With Atopic Dermatitis (AD) or Hidradenitis Suppurativa (HS)
NCT06938711A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast Cancer
NCT01616199Study of PX-866 and Vemurafenib in Patients With Advanced Melanoma
NCT02616484Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:
NCT03166085PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast Cancer
NCT06493552Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors
NCT02659215HyaloFAST Trial for Repair of Articular Cartilage in the Knee
NCT04052204Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors
NCT05050149Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations
NCT04421378A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
NCT0234708524-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003 and Placebo MDI
NCT04698915Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer
NCT00327652Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases
NCT07402876A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma
NCT04492033A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients
NCT07565285The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III Melanoma
NCT00219817Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss
NCT04240314AAV9 U7snRNA Gene Therapy to Treat Boys With DMD Exon 2 Duplications.
NCT06882031Evaluate the Pharmacokinetics of Oral Arsenic Trioxide Solution Under Fasting and Fed Conditions, to Compare Intravenous Arsenic Trioxide, in Acute Promyelocytic Leukemia
NCT06983028Atacicept in Multiple Glomerular Diseases
NCT07332000A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
NCT05530421Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma
NCT02666664Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)
NCT07279233To Assess the Enzyme Inducing Effects of Carbamazepine on the PK of Mirdametinib in Healthy Participants
NCT03337126Bioavailability of ATI-1501 With Taste Test Sub Study
NCT00616993Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-004)
NCT01729104Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
NCT04332432GT-032 Belapectin Hepatic Impairment
NCT03516305Pharmacokinetic Study Evaluating Staccato® Alprazolam 1 mg Inhaler in Smokers Versus Non-Smokers
NCT00045994The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling
NCT07755397First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor
NCT068961889-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)
NCT02628769A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary Disease
NCT03082118Vesair Continued Access Trial
NCT06099769A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
NCT06462183Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)
NCT06922890First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury
NCT02267460An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease
NCT02607683Phase 2b/3 Study of XAF5 Ointment for Steatoblepharon (Undereye Bags)
NCT04755283Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation
NCT04955262A CD8 Positron Emission Tomography With Computed Tomography (PET/CT) Study Using ⁸⁹Zr Df-IAB22M2C in Patients With Metastatic Melanoma Receiving Bempegaldesleukin (NKTR-214) and Nivolumab
NCT02593227Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer
NCT06672718A Study of SPY002-091 in Healthy Volunteers
NCT06944379ORKA-002-211 A Phase I Study to Evaluate ORKA-002 in Healthy Volunteers Following A Single Dose
NCT05828303A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors
NCT05579691A Double-Blind, Placebo-Controlled, Dose Exploration Study of CTI-1601 in Adult Subjects With Friedreich's Ataxia
NCT04410224Study of ASN004 in Patients With Advanced Solid Tumors
NCT04118868Pembrolizumab Administered Via the Sofusa® DoseConnect™ in Patients With Relapsed/Refractory Cutaneous T-cell Lymphoma.